Unique ID issued by UMIN | UMIN000053706 |
---|---|
Receipt number | R000061230 |
Scientific Title | Real World Characterization of Patients with Advanced or Metastatic Liposarcoma in Japan |
Date of disclosure of the study information | 2024/02/26 |
Last modified on | 2024/02/26 11:20:11 |
Real World Characterization of Patients with Advanced or Metastatic Liposarcoma in Japan
Real World Characterization of Patients with Advanced or Metastatic Liposarcoma in Japan
Real World Characterization of Patients with Advanced or Metastatic Liposarcoma in Japan
Real World Characterization of Patients with Advanced or Metastatic Liposarcoma in Japan
Japan |
Advanced or Metastatic Liposarcoma
Gastroenterology | Hematology and clinical oncology | Gastrointestinal surgery |
Orthopedics | Urology |
Malignancy
NO
To describe demographic and clinical characteristics, treatment status, and clinical outcomes of the patients with LPS, treated with systemic antineoplastic therapy in Japan.
Cohort1: Advanced or metastatic liposarcoma (LPS)
Cohort2: Advanced or metastatic dedifferentiated liposarcoma (DDLPS)
Cohort3: Advanced or metastatic well differentiated liposarcoma (WDLPS)
Others
Epidemiological study utilizing registry data
Exploratory
Others
Not applicable
Progression-free survival (PFS)
Overall survival (OS)
Overall response rate (ORR)
Disease control rate (DCR)
Observational
Not applicable |
Not applicable |
Male and Female
1. Patients with a diagnosis of LPS.
2. Patients with a history of systemic antineoplastic therapy for LPS.
None
103
1st name | Hitomi |
Middle name | |
Last name | Okuma |
National Cancer Center Hospital
International Research and Development Section, Clinical Research Support Office, Department of Breast and Medical Oncology
104-0045
5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan
03-3542-2511
hsumiyos@ncc.go.jp
1st name | Yuichi |
Middle name | |
Last name | Hirata |
Nippon Boehringer Ingelheim Co., Ltd
Oncology Pipeline Group, TA-Oncology Specialty Care Medicine
141-6017
2-1-1 Osaki, Shinagawa-ku, Tokyo, Japan
03-6417-2200
yuichi.hirata@boehringer-ingelheim.com
Nippon Boehringer Ingelheim Co., Ltd.
Yuichi Hirata
Nippon Boehringer Ingelheim Co., Ltd.
Profit organization
Takahashi Clinic Ethics Committee
Medicalhat 1F , 5-1-31, Iwayakita-machi, Nada-ku, Kobe-shi, Hyogo 657-0846
078-882-6432
kishimoto.satoshi@neues.co.jp
NO
2024 | Year | 02 | Month | 26 | Day |
Unpublished
100
No longer recruiting
2023 | Year | 07 | Month | 05 | Day |
2023 | Year | 08 | Month | 04 | Day |
2023 | Year | 08 | Month | 04 | Day |
2023 | Year | 08 | Month | 04 | Day |
2023 | Year | 08 | Month | 04 | Day |
2023 | Year | 08 | Month | 04 | Day |
2023 | Year | 11 | Month | 28 | Day |
A non-interventional/observational, cohort study using existing data (MASTER KEY Registry).
The MASTER KEY Registry began enrollment in May 2017, and this study used data with a cutoff of May 15, 2023 for patients who were enrolled by Dec 31, 2022.
This study aims to provide the most recent real-world information on the epidemiology of patients with advanced or metastatic LPS in Japan, including an understanding of the prevalence of genetic alterations and clinical outcomes.
2024 | Year | 02 | Month | 26 | Day |
2024 | Year | 02 | Month | 26 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000061230
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |